Bladder-cancer incidence in relation to vegetable and fruit consumption : a prospective study of atomic-bomb survivors

Auteur(s) :
Kono S., Koyama K., Mabuchi K., Moriwaki H., Nagano J., Preston DL., Sharp GB.
Date :
Avr, 2000
Source(s) :
INTERNATIONAL JOURNAL OF CANCER. #86:1 p132-138
Adresse :
"NAGANO J,RADIAT EFFECTS RES FDN,DEPT EPIDEMIOL MINAMI KU;5-2 HIJIYAMA PK;HIROSHIMA 7320815, JAPAN."

Sommaire de l'article

We examined the relation between consumption of 22 dietary items and subsequent bladder-cancer incidence in a cohort of atomic-bomb survivors in Japan. Subjects were 38,540 people (14,873 men and 23,667 women) who responded to a mail survey carried out between 1979 and 1981 and who had no known cancer diagnosed before the start of follow-up (1 January 1980 for men, 1 February 1981 for women), Consumption frequencies for 22 dietary items were ascertained with pre-coded answers. As of the end of 1993, there were 114 (83 men and 31 women) incident cases of bladder cancer among 450,326 person-years at risk. Statistical analysis was done using Poisson regression for grouped survival data. Consumption of green-yellow vegetables and fruit were protectively associated with risk. Adjusted for gender, age, radiation exposure, smoking status, educational level, body-mass index and calendar time. the relative risk (RR) for those consuming green-yellow vegetables 2-4 times per week and almost everyday was 0.62 [95% confidence interval (CI) 0.39-0.98] and 0.54 (95% CI 0.30-0.94) respectively, as compared with those consuming once per week or less. The corresponding RR for fruit consumption was 0.50 (0.30-0.81) and 0.62 (0.39-0.99) respectively. Chicken consumption was unexpectedly associated with decreased risk, but additional adjustment for consumption did not change the relation of green-yellow vegetables or of fruit to risk. The consumption of the other dietary items, including meat and green tea, was not: related to risk. The findings add to evidence that high consumption of vegetables and fruit are protective against bladder cancer.

Source : Pubmed
Retour